News Releases

Month Year

Month Year

May 22, 2023

Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
May 8, 2023

Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
May 5, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 4, 2023

Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
Apr 24, 2023

Insmed to Host Investor and Analyst Event on May 8, 2023
Apr 20, 2023

Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
Apr 6, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 31, 2023

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
Mar 24, 2023

Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
Mar 3, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation